| 0.2 |
1.6 |
GO:0086047 |
membrane depolarization during Purkinje myocyte cell action potential(GO:0086047) |
| 0.2 |
0.5 |
GO:0007037 |
vacuolar phosphate transport(GO:0007037) positive regulation of mitotic cell cycle DNA replication(GO:1903465) positive regulation of parathyroid hormone secretion(GO:2000830) |
| 0.2 |
0.9 |
GO:1904565 |
response to 1-oleoyl-sn-glycerol 3-phosphate(GO:1904565) cellular response to 1-oleoyl-sn-glycerol 3-phosphate(GO:1904566) |
| 0.2 |
0.8 |
GO:0008050 |
female courtship behavior(GO:0008050) |
| 0.2 |
0.5 |
GO:0060279 |
regulation of ovulation(GO:0060278) positive regulation of ovulation(GO:0060279) |
| 0.1 |
0.4 |
GO:0032223 |
negative regulation of synaptic transmission, cholinergic(GO:0032223) neurotransmitter receptor biosynthetic process(GO:0045212) |
| 0.1 |
0.4 |
GO:0008057 |
eye pigment granule organization(GO:0008057) |
| 0.1 |
0.4 |
GO:2000393 |
negative regulation of lamellipodium morphogenesis(GO:2000393) |
| 0.1 |
0.5 |
GO:2000851 |
positive regulation of cortisol secretion(GO:0051464) positive regulation of glucocorticoid secretion(GO:2000851) |
| 0.1 |
0.4 |
GO:0007506 |
gonadal mesoderm development(GO:0007506) |
| 0.1 |
0.4 |
GO:0034164 |
negative regulation of toll-like receptor 9 signaling pathway(GO:0034164) |
| 0.1 |
0.3 |
GO:0072361 |
regulation of glycolytic process by regulation of transcription from RNA polymerase II promoter(GO:0072361) |
| 0.1 |
0.5 |
GO:0033274 |
response to vitamin B2(GO:0033274) heterochromatin maintenance(GO:0070829) |
| 0.1 |
0.3 |
GO:1903410 |
lysine import(GO:0034226) L-lysine import(GO:0061461) L-lysine import into cell(GO:1903410) |
| 0.1 |
0.3 |
GO:0097187 |
dentinogenesis(GO:0097187) |
| 0.1 |
0.5 |
GO:1905072 |
apoptotic process involved in endocardial cushion morphogenesis(GO:0003277) intermediate mesoderm morphogenesis(GO:0048390) intermediate mesoderm formation(GO:0048391) intermediate mesodermal cell differentiation(GO:0048392) regulation of cardiac muscle fiber development(GO:0055018) positive regulation of cardiac muscle fiber development(GO:0055020) bud dilation involved in lung branching(GO:0060503) BMP signaling pathway involved in ureter morphogenesis(GO:0061149) renal system segmentation(GO:0061150) BMP signaling pathway involved in renal system segmentation(GO:0061151) pulmonary artery endothelial tube morphogenesis(GO:0061155) regulation of transcription from RNA polymerase II promoter involved in mesonephros development(GO:0061216) BMP signaling pathway involved in nephric duct formation(GO:0071893) negative regulation of branch elongation involved in ureteric bud branching(GO:0072096) negative regulation of branch elongation involved in ureteric bud branching by BMP signaling pathway(GO:0072097) anterior/posterior pattern specification involved in ureteric bud development(GO:0072099) specification of ureteric bud anterior/posterior symmetry(GO:0072100) specification of ureteric bud anterior/posterior symmetry by BMP signaling pathway(GO:0072101) ureter epithelial cell differentiation(GO:0072192) negative regulation of mesenchymal cell proliferation involved in ureter development(GO:0072200) positive regulation of cell proliferation involved in outflow tract morphogenesis(GO:1901964) cardiac jelly development(GO:1905072) regulation of metanephric S-shaped body morphogenesis(GO:2000004) negative regulation of metanephric S-shaped body morphogenesis(GO:2000005) regulation of metanephric comma-shaped body morphogenesis(GO:2000006) negative regulation of metanephric comma-shaped body morphogenesis(GO:2000007) |
| 0.1 |
0.3 |
GO:0060054 |
positive regulation of epithelial cell proliferation involved in wound healing(GO:0060054) |
| 0.1 |
0.6 |
GO:0009051 |
pentose-phosphate shunt, oxidative branch(GO:0009051) |
| 0.1 |
0.4 |
GO:0072299 |
visceral serous pericardium development(GO:0061032) negative regulation of metanephric glomerulus development(GO:0072299) negative regulation of metanephric glomerular mesangial cell proliferation(GO:0072302) |
| 0.1 |
0.5 |
GO:1904274 |
tricellular tight junction assembly(GO:1904274) |
| 0.1 |
0.4 |
GO:0098942 |
regulation of circadian sleep/wake cycle, wakefulness(GO:0010840) positive regulation of circadian sleep/wake cycle, wakefulness(GO:0010841) circadian sleep/wake cycle, wakefulness(GO:0042746) cytoskeletal matrix organization at active zone(GO:0048789) neurexin clustering involved in presynaptic membrane assembly(GO:0097115) retrograde trans-synaptic signaling by trans-synaptic protein complex(GO:0098942) |
| 0.1 |
0.4 |
GO:0042247 |
morphogenesis of follicular epithelium(GO:0016333) establishment or maintenance of polarity of follicular epithelium(GO:0016334) establishment of planar polarity of follicular epithelium(GO:0042247) |
| 0.1 |
0.1 |
GO:1902731 |
negative regulation of chondrocyte proliferation(GO:1902731) |
| 0.1 |
0.2 |
GO:0010621 |
negative regulation of transcription by transcription factor localization(GO:0010621) |
| 0.1 |
0.4 |
GO:0048073 |
regulation of eye pigmentation(GO:0048073) |
| 0.1 |
0.5 |
GO:1903788 |
mycotoxin catabolic process(GO:0043387) aflatoxin catabolic process(GO:0046223) organic heteropentacyclic compound catabolic process(GO:1901377) regulation of glutathione biosynthetic process(GO:1903786) positive regulation of glutathione biosynthetic process(GO:1903788) |
| 0.1 |
0.4 |
GO:0048749 |
compound eye development(GO:0048749) |
| 0.1 |
0.1 |
GO:1904761 |
negative regulation of myofibroblast differentiation(GO:1904761) |
| 0.1 |
0.2 |
GO:0070446 |
cellular response to caloric restriction(GO:0061433) negative regulation of oligodendrocyte progenitor proliferation(GO:0070446) |
| 0.1 |
0.7 |
GO:0001886 |
endothelial cell morphogenesis(GO:0001886) |
| 0.1 |
0.1 |
GO:0001755 |
neural crest cell migration(GO:0001755) |
| 0.1 |
0.5 |
GO:0030200 |
heparan sulfate proteoglycan catabolic process(GO:0030200) |
| 0.1 |
0.3 |
GO:0003430 |
growth plate cartilage chondrocyte growth(GO:0003430) |
| 0.1 |
0.2 |
GO:1904247 |
positive regulation of polynucleotide adenylyltransferase activity(GO:1904247) |
| 0.1 |
0.6 |
GO:0021842 |
directional guidance of interneurons involved in migration from the subpallium to the cortex(GO:0021840) chemorepulsion involved in interneuron migration from the subpallium to the cortex(GO:0021842) |
| 0.1 |
0.1 |
GO:0055003 |
cardiac myofibril assembly(GO:0055003) |
| 0.1 |
0.1 |
GO:2001076 |
thorax and anterior abdomen determination(GO:0007356) regulation of metanephric ureteric bud development(GO:2001074) positive regulation of metanephric ureteric bud development(GO:2001076) |
| 0.1 |
0.2 |
GO:0060744 |
thelarche(GO:0042695) mammary gland branching involved in thelarche(GO:0060744) |
| 0.1 |
0.2 |
GO:1900248 |
cytoplasmic translational elongation(GO:0002182) regulation of cytoplasmic translational elongation(GO:1900247) negative regulation of cytoplasmic translational elongation(GO:1900248) |
| 0.1 |
0.2 |
GO:0046271 |
phenylpropanoid catabolic process(GO:0046271) |
| 0.1 |
0.5 |
GO:0015811 |
L-cystine transport(GO:0015811) |
| 0.1 |
0.3 |
GO:1902228 |
mammary gland fat development(GO:0060611) positive regulation of macrophage colony-stimulating factor signaling pathway(GO:1902228) positive regulation of response to macrophage colony-stimulating factor(GO:1903971) positive regulation of cellular response to macrophage colony-stimulating factor stimulus(GO:1903974) positive regulation of microglial cell migration(GO:1904141) |
| 0.1 |
0.3 |
GO:1903588 |
negative regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:1903588) |
| 0.1 |
0.2 |
GO:0021538 |
epithalamus development(GO:0021538) habenula development(GO:0021986) general adaptation syndrome(GO:0051866) |
| 0.1 |
0.3 |
GO:0044752 |
response to human chorionic gonadotropin(GO:0044752) |
| 0.1 |
0.4 |
GO:0030035 |
microspike assembly(GO:0030035) |
| 0.1 |
0.2 |
GO:2000705 |
dense core granule biogenesis(GO:0061110) regulation of dense core granule biogenesis(GO:2000705) |
| 0.1 |
0.1 |
GO:0060266 |
respiratory burst involved in inflammatory response(GO:0002536) regulation of respiratory burst involved in inflammatory response(GO:0060264) negative regulation of respiratory burst involved in inflammatory response(GO:0060266) |
| 0.1 |
0.2 |
GO:1905246 |
regulation of choline O-acetyltransferase activity(GO:1902769) positive regulation of choline O-acetyltransferase activity(GO:1902771) negative regulation of tau-protein kinase activity(GO:1902948) positive regulation of early endosome to recycling endosome transport(GO:1902955) negative regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902960) negative regulation of neurofibrillary tangle assembly(GO:1902997) negative regulation of aspartic-type peptidase activity(GO:1905246) |
| 0.1 |
0.5 |
GO:0045218 |
zonula adherens maintenance(GO:0045218) |
| 0.1 |
0.6 |
GO:0031580 |
membrane raft polarization(GO:0001766) membrane raft distribution(GO:0031580) |
| 0.1 |
0.3 |
GO:0002528 |
regulation of vascular permeability involved in acute inflammatory response(GO:0002528) |
| 0.1 |
0.2 |
GO:0044028 |
DNA hypomethylation(GO:0044028) hypomethylation of CpG island(GO:0044029) |
| 0.1 |
0.1 |
GO:0048319 |
axial mesoderm morphogenesis(GO:0048319) |
| 0.1 |
0.1 |
GO:0060061 |
Spemann organizer formation(GO:0060061) |
| 0.1 |
0.2 |
GO:0052553 |
induction by symbiont of host defense response(GO:0044416) induction of host immune response by virus(GO:0046730) active induction of host immune response by virus(GO:0046732) modulation by symbiont of host defense response(GO:0052031) induction by organism of defense response of other organism involved in symbiotic interaction(GO:0052251) modulation by organism of defense response of other organism involved in symbiotic interaction(GO:0052255) positive regulation by symbiont of host defense response(GO:0052509) positive regulation by organism of defense response of other organism involved in symbiotic interaction(GO:0052510) modulation by organism of immune response of other organism involved in symbiotic interaction(GO:0052552) modulation by symbiont of host immune response(GO:0052553) modulation by virus of host immune response(GO:0075528) |
| 0.1 |
0.5 |
GO:0038026 |
reelin-mediated signaling pathway(GO:0038026) |
| 0.1 |
0.2 |
GO:1905075 |
occluding junction disassembly(GO:1905071) regulation of occluding junction disassembly(GO:1905073) positive regulation of occluding junction disassembly(GO:1905075) |
| 0.0 |
0.1 |
GO:0032849 |
positive regulation of cellular pH reduction(GO:0032849) |
| 0.0 |
0.0 |
GO:0010915 |
regulation of very-low-density lipoprotein particle clearance(GO:0010915) negative regulation of very-low-density lipoprotein particle clearance(GO:0010916) |
| 0.0 |
0.0 |
GO:0030225 |
macrophage differentiation(GO:0030225) |
| 0.0 |
0.1 |
GO:0043095 |
regulation of GTP cyclohydrolase I activity(GO:0043095) negative regulation of GTP cyclohydrolase I activity(GO:0043105) |
| 0.0 |
0.3 |
GO:0019355 |
nicotinamide nucleotide biosynthetic process from aspartate(GO:0019355) 'de novo' NAD biosynthetic process from aspartate(GO:0034628) |
| 0.0 |
0.1 |
GO:2000224 |
regulation of testosterone biosynthetic process(GO:2000224) |
| 0.0 |
0.1 |
GO:0060664 |
epithelial cell proliferation involved in salivary gland morphogenesis(GO:0060664) |
| 0.0 |
0.0 |
GO:0010944 |
negative regulation of transcription by competitive promoter binding(GO:0010944) |
| 0.0 |
0.1 |
GO:0007509 |
mesoderm migration involved in gastrulation(GO:0007509) |
| 0.0 |
0.2 |
GO:0097089 |
methyl-branched fatty acid metabolic process(GO:0097089) |
| 0.0 |
0.1 |
GO:1900673 |
olefin metabolic process(GO:1900673) |
| 0.0 |
0.1 |
GO:0071812 |
circadian temperature homeostasis(GO:0060086) regulation of fever generation by regulation of prostaglandin secretion(GO:0071810) positive regulation of fever generation by positive regulation of prostaglandin secretion(GO:0071812) positive regulation of ERK1 and ERK2 cascade via TNFSF11-mediated signaling(GO:0071848) regulation of fever generation by prostaglandin secretion(GO:0100009) |
| 0.0 |
0.1 |
GO:2000563 |
positive regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000563) |
| 0.0 |
0.3 |
GO:0015015 |
heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
| 0.0 |
0.1 |
GO:0043012 |
regulation of fusion of sperm to egg plasma membrane(GO:0043012) |
| 0.0 |
0.0 |
GO:0009445 |
putrescine metabolic process(GO:0009445) |
| 0.0 |
0.0 |
GO:0061098 |
positive regulation of protein tyrosine kinase activity(GO:0061098) |
| 0.0 |
0.9 |
GO:0019800 |
peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
| 0.0 |
0.3 |
GO:1903527 |
positive regulation of membrane tubulation(GO:1903527) |
| 0.0 |
0.0 |
GO:0032095 |
regulation of response to food(GO:0032095) |
| 0.0 |
0.3 |
GO:1902866 |
regulation of retina development in camera-type eye(GO:1902866) |
| 0.0 |
0.2 |
GO:0030538 |
embryonic genitalia morphogenesis(GO:0030538) |
| 0.0 |
0.4 |
GO:0060267 |
positive regulation of respiratory burst(GO:0060267) |
| 0.0 |
0.0 |
GO:2000137 |
negative regulation of cell proliferation involved in heart morphogenesis(GO:2000137) |
| 0.0 |
0.2 |
GO:0021812 |
neuronal-glial interaction involved in cerebral cortex radial glia guided migration(GO:0021812) |
| 0.0 |
0.2 |
GO:0009138 |
pyrimidine nucleoside diphosphate metabolic process(GO:0009138) |
| 0.0 |
0.4 |
GO:0046898 |
response to cycloheximide(GO:0046898) |
| 0.0 |
0.6 |
GO:2000507 |
positive regulation of energy homeostasis(GO:2000507) |
| 0.0 |
0.1 |
GO:1902559 |
3'-phosphoadenosine 5'-phosphosulfate transport(GO:0046963) 3'-phospho-5'-adenylyl sulfate transmembrane transport(GO:1902559) |
| 0.0 |
0.2 |
GO:0021797 |
forebrain anterior/posterior pattern specification(GO:0021797) |
| 0.0 |
0.2 |
GO:0060040 |
retinal bipolar neuron differentiation(GO:0060040) |
| 0.0 |
0.2 |
GO:0060160 |
negative regulation of dopamine receptor signaling pathway(GO:0060160) |
| 0.0 |
0.0 |
GO:0035990 |
tendon cell differentiation(GO:0035990) tendon formation(GO:0035992) |
| 0.0 |
0.4 |
GO:2000343 |
positive regulation of chemokine (C-X-C motif) ligand 2 production(GO:2000343) |
| 0.0 |
0.2 |
GO:0061107 |
seminal vesicle development(GO:0061107) |
| 0.0 |
0.1 |
GO:0031548 |
regulation of brain-derived neurotrophic factor receptor signaling pathway(GO:0031548) |
| 0.0 |
0.4 |
GO:0042997 |
negative regulation of Golgi to plasma membrane protein transport(GO:0042997) |
| 0.0 |
0.2 |
GO:1903300 |
negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
| 0.0 |
0.1 |
GO:0061030 |
epithelial cell differentiation involved in mammary gland alveolus development(GO:0061030) |
| 0.0 |
0.1 |
GO:1903570 |
regulation of protein kinase D signaling(GO:1903570) positive regulation of protein kinase D signaling(GO:1903572) |
| 0.0 |
0.2 |
GO:0060754 |
positive regulation of mast cell chemotaxis(GO:0060754) |
| 0.0 |
0.1 |
GO:0071284 |
cellular response to lead ion(GO:0071284) |
| 0.0 |
0.1 |
GO:1903949 |
positive regulation of atrial cardiac muscle cell action potential(GO:1903949) |
| 0.0 |
0.1 |
GO:0061760 |
antifungal innate immune response(GO:0061760) |
| 0.0 |
0.1 |
GO:1903347 |
negative regulation of bicellular tight junction assembly(GO:1903347) |
| 0.0 |
0.1 |
GO:0045110 |
intermediate filament bundle assembly(GO:0045110) |
| 0.0 |
0.1 |
GO:0046338 |
phosphatidylethanolamine catabolic process(GO:0046338) |
| 0.0 |
0.2 |
GO:0048133 |
germ-line stem cell division(GO:0042078) male germ-line stem cell asymmetric division(GO:0048133) germline stem cell asymmetric division(GO:0098728) |
| 0.0 |
0.1 |
GO:1904049 |
negative regulation of spontaneous neurotransmitter secretion(GO:1904049) |
| 0.0 |
0.3 |
GO:0034154 |
toll-like receptor 7 signaling pathway(GO:0034154) |
| 0.0 |
0.1 |
GO:0061304 |
retinal blood vessel morphogenesis(GO:0061304) |
| 0.0 |
0.2 |
GO:0035426 |
extracellular matrix-cell signaling(GO:0035426) |
| 0.0 |
0.1 |
GO:0051389 |
inactivation of MAPKK activity(GO:0051389) |
| 0.0 |
0.2 |
GO:0030644 |
cellular chloride ion homeostasis(GO:0030644) |
| 0.0 |
0.5 |
GO:0033601 |
positive regulation of mammary gland epithelial cell proliferation(GO:0033601) |
| 0.0 |
0.2 |
GO:0060535 |
trachea cartilage morphogenesis(GO:0060535) |
| 0.0 |
1.2 |
GO:0031581 |
hemidesmosome assembly(GO:0031581) |
| 0.0 |
0.1 |
GO:0003338 |
metanephros morphogenesis(GO:0003338) |
| 0.0 |
0.2 |
GO:2000048 |
negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
| 0.0 |
0.1 |
GO:0034124 |
regulation of MyD88-dependent toll-like receptor signaling pathway(GO:0034124) |
| 0.0 |
0.2 |
GO:0003404 |
optic vesicle morphogenesis(GO:0003404) optic cup structural organization(GO:0003409) |
| 0.0 |
0.0 |
GO:0036462 |
TRAIL-activated apoptotic signaling pathway(GO:0036462) |
| 0.0 |
0.1 |
GO:0033024 |
mast cell homeostasis(GO:0033023) mast cell apoptotic process(GO:0033024) regulation of mast cell apoptotic process(GO:0033025) |
| 0.0 |
0.1 |
GO:2000015 |
regulation of determination of dorsal identity(GO:2000015) |
| 0.0 |
0.1 |
GO:0006102 |
isocitrate metabolic process(GO:0006102) |
| 0.0 |
0.2 |
GO:0015722 |
canalicular bile acid transport(GO:0015722) |
| 0.0 |
0.5 |
GO:0060068 |
vagina development(GO:0060068) |
| 0.0 |
0.1 |
GO:0019521 |
aldonic acid metabolic process(GO:0019520) D-gluconate metabolic process(GO:0019521) |
| 0.0 |
0.2 |
GO:0038030 |
non-canonical Wnt signaling pathway via MAPK cascade(GO:0038030) |
| 0.0 |
0.0 |
GO:2000138 |
positive regulation of cell proliferation involved in heart morphogenesis(GO:2000138) |
| 0.0 |
0.0 |
GO:0090118 |
receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport(GO:0090118) |
| 0.0 |
0.0 |
GO:0043589 |
skin morphogenesis(GO:0043589) |
| 0.0 |
0.1 |
GO:0001782 |
B cell homeostasis(GO:0001782) |
| 0.0 |
0.1 |
GO:0031587 |
positive regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0031587) |
| 0.0 |
0.1 |
GO:1903984 |
positive regulation of TRAIL-activated apoptotic signaling pathway(GO:1903984) |
| 0.0 |
0.4 |
GO:0016554 |
cytidine to uridine editing(GO:0016554) |
| 0.0 |
0.0 |
GO:0061000 |
negative regulation of dendritic spine development(GO:0061000) |
| 0.0 |
0.1 |
GO:0060809 |
mesodermal to mesenchymal transition involved in gastrulation(GO:0060809) |
| 0.0 |
0.0 |
GO:0035802 |
adrenal cortex development(GO:0035801) adrenal cortex formation(GO:0035802) |
| 0.0 |
0.0 |
GO:1904000 |
positive regulation of eating behavior(GO:1904000) |
| 0.0 |
0.1 |
GO:0043335 |
protein unfolding(GO:0043335) |
| 0.0 |
0.1 |
GO:0019254 |
carnitine metabolic process, CoA-linked(GO:0019254) |
| 0.0 |
0.3 |
GO:2001013 |
epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
| 0.0 |
0.4 |
GO:0032926 |
negative regulation of activin receptor signaling pathway(GO:0032926) |
| 0.0 |
0.1 |
GO:0035752 |
lysosomal lumen pH elevation(GO:0035752) |
| 0.0 |
0.1 |
GO:1904933 |
regulation of cell proliferation in midbrain(GO:1904933) |
| 0.0 |
0.1 |
GO:0035408 |
histone H3-T6 phosphorylation(GO:0035408) |
| 0.0 |
0.2 |
GO:0060672 |
epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
| 0.0 |
0.0 |
GO:0048525 |
negative regulation of viral process(GO:0048525) |
| 0.0 |
0.4 |
GO:0030949 |
positive regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030949) |
| 0.0 |
0.6 |
GO:0031065 |
positive regulation of histone deacetylation(GO:0031065) |
| 0.0 |
0.3 |
GO:0061002 |
negative regulation of dendritic spine morphogenesis(GO:0061002) |
| 0.0 |
0.1 |
GO:0051088 |
PMA-inducible membrane protein ectodomain proteolysis(GO:0051088) |
| 0.0 |
0.2 |
GO:0015798 |
myo-inositol transport(GO:0015798) |
| 0.0 |
0.3 |
GO:0006528 |
asparagine metabolic process(GO:0006528) |
| 0.0 |
0.1 |
GO:0002372 |
myeloid dendritic cell cytokine production(GO:0002372) |
| 0.0 |
0.6 |
GO:0048681 |
negative regulation of axon regeneration(GO:0048681) negative regulation of neuron projection regeneration(GO:0070571) |
| 0.0 |
0.1 |
GO:0097252 |
oligodendrocyte apoptotic process(GO:0097252) |
| 0.0 |
0.1 |
GO:1902823 |
negative regulation of late endosome to lysosome transport(GO:1902823) |
| 0.0 |
0.1 |
GO:0060425 |
lung morphogenesis(GO:0060425) |
| 0.0 |
0.1 |
GO:2001027 |
negative regulation of endothelial cell chemotaxis(GO:2001027) |
| 0.0 |
0.4 |
GO:1990403 |
embryonic brain development(GO:1990403) |
| 0.0 |
0.2 |
GO:0035879 |
plasma membrane lactate transport(GO:0035879) |
| 0.0 |
0.1 |
GO:0003131 |
mesodermal-endodermal cell signaling(GO:0003131) programmed DNA elimination(GO:0031049) chromosome breakage(GO:0031052) histone H2A-S139 phosphorylation(GO:0035978) positive regulation of cellular response to X-ray(GO:2000685) |
| 0.0 |
0.1 |
GO:0090244 |
Wnt signaling pathway involved in somitogenesis(GO:0090244) |
| 0.0 |
0.1 |
GO:0033319 |
UDP-D-xylose metabolic process(GO:0033319) UDP-D-xylose biosynthetic process(GO:0033320) |
| 0.0 |
0.2 |
GO:0098904 |
regulation of AV node cell action potential(GO:0098904) |
| 0.0 |
0.0 |
GO:0035986 |
senescence-associated heterochromatin focus assembly(GO:0035986) oncogene-induced cell senescence(GO:0090402) |
| 0.0 |
0.1 |
GO:0051562 |
negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
| 0.0 |
0.4 |
GO:0021859 |
pyramidal neuron differentiation(GO:0021859) pyramidal neuron development(GO:0021860) |
| 0.0 |
0.4 |
GO:1903012 |
positive regulation of bone development(GO:1903012) |
| 0.0 |
0.2 |
GO:0030421 |
defecation(GO:0030421) |
| 0.0 |
0.1 |
GO:0050882 |
voluntary musculoskeletal movement(GO:0050882) |
| 0.0 |
0.1 |
GO:0042357 |
thiamine diphosphate metabolic process(GO:0042357) |
| 0.0 |
0.1 |
GO:0006218 |
uridine catabolic process(GO:0006218) |
| 0.0 |
0.2 |
GO:0001550 |
ovarian cumulus expansion(GO:0001550) fused antrum stage(GO:0048165) |
| 0.0 |
0.6 |
GO:0007175 |
negative regulation of epidermal growth factor-activated receptor activity(GO:0007175) |
| 0.0 |
0.1 |
GO:1904978 |
regulation of endosome organization(GO:1904978) |
| 0.0 |
0.2 |
GO:1900194 |
negative regulation of oocyte maturation(GO:1900194) |
| 0.0 |
0.1 |
GO:1901526 |
positive regulation of macromitophagy(GO:1901526) positive regulation of mitophagy in response to mitochondrial depolarization(GO:1904925) |
| 0.0 |
0.1 |
GO:1904245 |
regulation of polynucleotide adenylyltransferase activity(GO:1904245) |
| 0.0 |
0.2 |
GO:0018242 |
protein O-linked glycosylation via serine(GO:0018242) |
| 0.0 |
0.1 |
GO:0061181 |
regulation of chondrocyte development(GO:0061181) |
| 0.0 |
0.1 |
GO:0038169 |
somatostatin receptor signaling pathway(GO:0038169) somatostatin signaling pathway(GO:0038170) |
| 0.0 |
0.1 |
GO:0007439 |
ectodermal digestive tract development(GO:0007439) embryonic ectodermal digestive tract development(GO:0048611) |
| 0.0 |
0.1 |
GO:0021586 |
pons maturation(GO:0021586) superior olivary nucleus development(GO:0021718) superior olivary nucleus maturation(GO:0021722) |
| 0.0 |
0.1 |
GO:2000820 |
negative regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000820) |
| 0.0 |
0.1 |
GO:0060574 |
intestinal epithelial cell maturation(GO:0060574) |
| 0.0 |
0.3 |
GO:0060120 |
auditory receptor cell fate commitment(GO:0009912) inner ear receptor cell fate commitment(GO:0060120) |
| 0.0 |
0.2 |
GO:0051697 |
protein delipidation(GO:0051697) |
| 0.0 |
0.1 |
GO:1900133 |
regulation of renin secretion into blood stream(GO:1900133) |
| 0.0 |
0.1 |
GO:0071955 |
recycling endosome to Golgi transport(GO:0071955) |
| 0.0 |
0.2 |
GO:0060174 |
limb bud formation(GO:0060174) |
| 0.0 |
0.1 |
GO:0019747 |
regulation of isoprenoid metabolic process(GO:0019747) |
| 0.0 |
0.1 |
GO:0032792 |
negative regulation of CREB transcription factor activity(GO:0032792) |
| 0.0 |
0.1 |
GO:0042412 |
taurine biosynthetic process(GO:0042412) |
| 0.0 |
0.0 |
GO:1903207 |
neuron death in response to hydrogen peroxide(GO:0036476) regulation of hydrogen peroxide-induced neuron death(GO:1903207) negative regulation of hydrogen peroxide-induced neuron death(GO:1903208) |
| 0.0 |
0.1 |
GO:0010816 |
substance P catabolic process(GO:0010814) calcitonin catabolic process(GO:0010816) endothelin maturation(GO:0034959) |
| 0.0 |
0.1 |
GO:1903615 |
regulation of protein tyrosine phosphatase activity(GO:1903613) positive regulation of protein tyrosine phosphatase activity(GO:1903615) |
| 0.0 |
0.2 |
GO:0035583 |
sequestering of TGFbeta in extracellular matrix(GO:0035583) |
| 0.0 |
0.1 |
GO:0006742 |
NADP catabolic process(GO:0006742) pyridine nucleotide catabolic process(GO:0019364) |
| 0.0 |
0.0 |
GO:0042491 |
auditory receptor cell differentiation(GO:0042491) |
| 0.0 |
0.0 |
GO:1901187 |
regulation of ephrin receptor signaling pathway(GO:1901187) |
| 0.0 |
0.2 |
GO:0032439 |
endosome localization(GO:0032439) |
| 0.0 |
0.1 |
GO:0002415 |
immune response in mucosal-associated lymphoid tissue(GO:0002386) immunoglobulin transcytosis in epithelial cells mediated by polymeric immunoglobulin receptor(GO:0002415) |
| 0.0 |
0.1 |
GO:0014839 |
myoblast migration involved in skeletal muscle regeneration(GO:0014839) |
| 0.0 |
0.0 |
GO:0000429 |
carbon catabolite regulation of transcription from RNA polymerase II promoter(GO:0000429) carbon catabolite activation of transcription from RNA polymerase II promoter(GO:0000436) |
| 0.0 |
0.0 |
GO:0043311 |
positive regulation of eosinophil degranulation(GO:0043311) positive regulation of eosinophil activation(GO:1902568) |
| 0.0 |
0.0 |
GO:0061198 |
fungiform papilla formation(GO:0061198) |
| 0.0 |
0.1 |
GO:2000661 |
positive regulation of interleukin-1-mediated signaling pathway(GO:2000661) |
| 0.0 |
0.1 |
GO:0003408 |
optic cup formation involved in camera-type eye development(GO:0003408) |
| 0.0 |
0.0 |
GO:0045163 |
clustering of voltage-gated potassium channels(GO:0045163) |
| 0.0 |
0.1 |
GO:0071651 |
positive regulation of chemokine (C-C motif) ligand 5 production(GO:0071651) |
| 0.0 |
0.1 |
GO:0010760 |
negative regulation of macrophage chemotaxis(GO:0010760) |
| 0.0 |
0.1 |
GO:0006990 |
positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response(GO:0006990) |
| 0.0 |
0.1 |
GO:0016340 |
calcium-dependent cell-matrix adhesion(GO:0016340) |
| 0.0 |
0.0 |
GO:1902947 |
regulation of tau-protein kinase activity(GO:1902947) |
| 0.0 |
0.1 |
GO:0030309 |
poly-N-acetyllactosamine metabolic process(GO:0030309) |
| 0.0 |
0.2 |
GO:0097039 |
protein linear polyubiquitination(GO:0097039) |
| 0.0 |
0.1 |
GO:0002154 |
thyroid hormone mediated signaling pathway(GO:0002154) regulation of thyroid hormone mediated signaling pathway(GO:0002155) |
| 0.0 |
0.2 |
GO:0006880 |
intracellular sequestering of iron ion(GO:0006880) sequestering of iron ion(GO:0097577) |
| 0.0 |
0.1 |
GO:0000101 |
sulfur amino acid transport(GO:0000101) |
| 0.0 |
0.1 |
GO:1904217 |
regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
| 0.0 |
0.1 |
GO:0033088 |
negative regulation of immature T cell proliferation in thymus(GO:0033088) |
| 0.0 |
0.0 |
GO:1901896 |
positive regulation of calcium-transporting ATPase activity(GO:1901896) |
| 0.0 |
0.1 |
GO:0034402 |
recruitment of 3'-end processing factors to RNA polymerase II holoenzyme complex(GO:0034402) |
| 0.0 |
0.1 |
GO:1902715 |
positive regulation of interferon-gamma secretion(GO:1902715) |
| 0.0 |
0.2 |
GO:0051005 |
negative regulation of lipoprotein lipase activity(GO:0051005) |
| 0.0 |
0.1 |
GO:0097527 |
necroptotic signaling pathway(GO:0097527) |
| 0.0 |
0.1 |
GO:0000270 |
peptidoglycan metabolic process(GO:0000270) peptidoglycan catabolic process(GO:0009253) |
| 0.0 |
0.0 |
GO:0046543 |
development of secondary sexual characteristics(GO:0045136) development of secondary female sexual characteristics(GO:0046543) |
| 0.0 |
0.0 |
GO:0006680 |
glucosylceramide catabolic process(GO:0006680) |
| 0.0 |
0.1 |
GO:0033364 |
mast cell secretory granule organization(GO:0033364) |
| 0.0 |
0.0 |
GO:0070827 |
chromatin maintenance(GO:0070827) |
| 0.0 |
0.0 |
GO:2000307 |
tumor necrosis factor (ligand) superfamily member 11 production(GO:0072535) regulation of tumor necrosis factor (ligand) superfamily member 11 production(GO:2000307) positive regulation of thymocyte migration(GO:2000412) |
| 0.0 |
0.1 |
GO:1902523 |
positive regulation of protein K63-linked ubiquitination(GO:1902523) |
| 0.0 |
0.0 |
GO:0048388 |
endosomal lumen acidification(GO:0048388) |
| 0.0 |
0.2 |
GO:0048105 |
establishment of body hair or bristle planar orientation(GO:0048104) establishment of body hair planar orientation(GO:0048105) |
| 0.0 |
0.4 |
GO:0019511 |
peptidyl-proline hydroxylation(GO:0019511) |
| 0.0 |
0.1 |
GO:0060689 |
cell differentiation involved in salivary gland development(GO:0060689) |
| 0.0 |
0.1 |
GO:0009107 |
lipoate biosynthetic process(GO:0009107) |
| 0.0 |
0.1 |
GO:0010273 |
detoxification of copper ion(GO:0010273) stress response to copper ion(GO:1990169) |
| 0.0 |
0.1 |
GO:0018094 |
protein polyglycylation(GO:0018094) |
| 0.0 |
0.1 |
GO:0031179 |
peptide amidation(GO:0001519) protein amidation(GO:0018032) peptide modification(GO:0031179) |
| 0.0 |
0.0 |
GO:0021536 |
diencephalon development(GO:0021536) |
| 0.0 |
0.1 |
GO:0035022 |
positive regulation of Rac protein signal transduction(GO:0035022) |
| 0.0 |
0.4 |
GO:0010818 |
T cell chemotaxis(GO:0010818) |
| 0.0 |
0.0 |
GO:0060027 |
convergent extension involved in gastrulation(GO:0060027) |
| 0.0 |
0.1 |
GO:1904211 |
membrane protein proteolysis involved in retrograde protein transport, ER to cytosol(GO:1904211) |
| 0.0 |
0.1 |
GO:1904674 |
positive regulation of somatic stem cell population maintenance(GO:1904674) |
| 0.0 |
0.3 |
GO:0044341 |
sodium-dependent phosphate transport(GO:0044341) |
| 0.0 |
0.1 |
GO:1990709 |
presynaptic active zone organization(GO:1990709) |
| 0.0 |
0.1 |
GO:0034499 |
late endosome to Golgi transport(GO:0034499) |
| 0.0 |
0.1 |
GO:0042360 |
vitamin E metabolic process(GO:0042360) |
| 0.0 |
0.0 |
GO:0006670 |
sphingosine metabolic process(GO:0006670) |
| 0.0 |
0.1 |
GO:0090131 |
mesenchyme migration(GO:0090131) |
| 0.0 |
0.0 |
GO:0045994 |
positive regulation of translational initiation by iron(GO:0045994) |
| 0.0 |
0.3 |
GO:0051446 |
positive regulation of meiotic cell cycle(GO:0051446) |
| 0.0 |
0.3 |
GO:0043402 |
glucocorticoid mediated signaling pathway(GO:0043402) |
| 0.0 |
0.1 |
GO:0070164 |
negative regulation of adiponectin secretion(GO:0070164) |
| 0.0 |
0.0 |
GO:1904397 |
negative regulation of neuromuscular junction development(GO:1904397) |
| 0.0 |
0.1 |
GO:0002541 |
activation of plasma proteins involved in acute inflammatory response(GO:0002541) |
| 0.0 |
0.0 |
GO:0008063 |
Toll signaling pathway(GO:0008063) |
| 0.0 |
0.2 |
GO:2000601 |
positive regulation of Arp2/3 complex-mediated actin nucleation(GO:2000601) |
| 0.0 |
0.2 |
GO:2001171 |
positive regulation of ATP biosynthetic process(GO:2001171) |
| 0.0 |
0.2 |
GO:0032417 |
positive regulation of sodium:proton antiporter activity(GO:0032417) |
| 0.0 |
0.1 |
GO:0032218 |
riboflavin transport(GO:0032218) |
| 0.0 |
0.2 |
GO:1902748 |
mammillary body development(GO:0021767) mammillary axonal complex development(GO:0061373) positive regulation of lens fiber cell differentiation(GO:1902748) |
| 0.0 |
0.0 |
GO:0000422 |
mitophagy(GO:0000422) mitochondrion disassembly(GO:0061726) |
| 0.0 |
0.1 |
GO:0014022 |
neural plate elongation(GO:0014022) convergent extension involved in neural plate elongation(GO:0022007) |
| 0.0 |
0.1 |
GO:0061580 |
colon epithelial cell migration(GO:0061580) |
| 0.0 |
0.0 |
GO:0002934 |
desmosome organization(GO:0002934) |
| 0.0 |
0.1 |
GO:0090222 |
centrosome-templated microtubule nucleation(GO:0090222) |
| 0.0 |
0.0 |
GO:0032915 |
positive regulation of transforming growth factor beta2 production(GO:0032915) |
| 0.0 |
0.0 |
GO:0060268 |
negative regulation of respiratory burst(GO:0060268) |
| 0.0 |
0.1 |
GO:2000097 |
regulation of smooth muscle cell-matrix adhesion(GO:2000097) |
| 0.0 |
0.2 |
GO:0046618 |
drug export(GO:0046618) |
| 0.0 |
0.2 |
GO:0046415 |
urate metabolic process(GO:0046415) |
| 0.0 |
0.0 |
GO:0015670 |
carbon dioxide transport(GO:0015670) |
| 0.0 |
0.0 |
GO:0072301 |
regulation of metanephric glomerular mesangial cell proliferation(GO:0072301) |
| 0.0 |
0.2 |
GO:0060856 |
establishment of blood-brain barrier(GO:0060856) |
| 0.0 |
0.1 |
GO:0043353 |
enucleate erythrocyte differentiation(GO:0043353) |
| 0.0 |
0.0 |
GO:0097091 |
synaptic vesicle clustering(GO:0097091) |
| 0.0 |
0.1 |
GO:0021793 |
chemorepulsion of branchiomotor axon(GO:0021793) |
| 0.0 |
0.1 |
GO:0018352 |
protein-pyridoxal-5-phosphate linkage(GO:0018352) |
| 0.0 |
0.0 |
GO:0045715 |
negative regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045715) |
| 0.0 |
0.1 |
GO:0036512 |
trimming of terminal mannose on B branch(GO:0036509) trimming of first mannose on A branch(GO:0036511) trimming of second mannose on A branch(GO:0036512) |
| 0.0 |
0.1 |
GO:0036289 |
peptidyl-serine autophosphorylation(GO:0036289) |
| 0.0 |
0.1 |
GO:0051490 |
negative regulation of filopodium assembly(GO:0051490) |
| 0.0 |
0.1 |
GO:1902679 |
negative regulation of RNA biosynthetic process(GO:1902679) |
| 0.0 |
0.0 |
GO:2000182 |
regulation of progesterone biosynthetic process(GO:2000182) |
| 0.0 |
0.1 |
GO:0031443 |
fast-twitch skeletal muscle fiber contraction(GO:0031443) |
| 0.0 |
0.1 |
GO:0090206 |
negative regulation of cholesterol biosynthetic process(GO:0045541) negative regulation of cholesterol metabolic process(GO:0090206) |
| 0.0 |
0.1 |
GO:0044778 |
meiotic DNA integrity checkpoint(GO:0044778) |
| 0.0 |
0.0 |
GO:0010666 |
positive regulation of striated muscle cell apoptotic process(GO:0010663) positive regulation of cardiac muscle cell apoptotic process(GO:0010666) |
| 0.0 |
0.1 |
GO:0051684 |
maintenance of Golgi location(GO:0051684) |
| 0.0 |
0.2 |
GO:2000346 |
negative regulation of hepatocyte proliferation(GO:2000346) |
| 0.0 |
0.0 |
GO:0060373 |
regulation of ventricular cardiac muscle cell membrane depolarization(GO:0060373) |
| 0.0 |
0.1 |
GO:0090038 |
negative regulation of protein kinase C signaling(GO:0090038) |
| 0.0 |
0.1 |
GO:1903281 |
positive regulation of calcium:sodium antiporter activity(GO:1903281) |
| 0.0 |
0.2 |
GO:0043152 |
induction of bacterial agglutination(GO:0043152) |
| 0.0 |
0.2 |
GO:0045603 |
positive regulation of endothelial cell differentiation(GO:0045603) |
| 0.0 |
0.1 |
GO:1905205 |
positive regulation of connective tissue replacement(GO:1905205) |
| 0.0 |
0.1 |
GO:0061535 |
glutamate secretion, neurotransmission(GO:0061535) |
| 0.0 |
0.1 |
GO:0002368 |
B cell cytokine production(GO:0002368) |
| 0.0 |
0.1 |
GO:0046462 |
monoacylglycerol metabolic process(GO:0046462) monoacylglycerol catabolic process(GO:0052651) |
| 0.0 |
0.0 |
GO:0035989 |
tendon development(GO:0035989) |
| 0.0 |
0.3 |
GO:0015871 |
choline transport(GO:0015871) |
| 0.0 |
0.3 |
GO:0070050 |
neuron cellular homeostasis(GO:0070050) |
| 0.0 |
0.2 |
GO:0001887 |
selenium compound metabolic process(GO:0001887) |
| 0.0 |
0.3 |
GO:0061635 |
regulation of protein complex stability(GO:0061635) |
| 0.0 |
0.3 |
GO:0035269 |
protein O-linked mannosylation(GO:0035269) |
| 0.0 |
0.6 |
GO:0070884 |
regulation of calcineurin-NFAT signaling cascade(GO:0070884) |
| 0.0 |
0.1 |
GO:0050653 |
chondroitin sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0050653) |
| 0.0 |
0.0 |
GO:0001702 |
gastrulation with mouth forming second(GO:0001702) |
| 0.0 |
0.1 |
GO:0010459 |
negative regulation of heart rate(GO:0010459) |
| 0.0 |
0.3 |
GO:1904262 |
negative regulation of TORC1 signaling(GO:1904262) |
| 0.0 |
0.2 |
GO:0030050 |
vesicle transport along actin filament(GO:0030050) |
| 0.0 |
0.2 |
GO:0035988 |
chondrocyte proliferation(GO:0035988) |
| 0.0 |
0.4 |
GO:0043116 |
negative regulation of vascular permeability(GO:0043116) |
| 0.0 |
0.2 |
GO:1900029 |
positive regulation of ruffle assembly(GO:1900029) |
| 0.0 |
0.0 |
GO:0097237 |
cellular response to toxic substance(GO:0097237) |
| 0.0 |
0.1 |
GO:0071028 |
RNA surveillance(GO:0071025) nuclear RNA surveillance(GO:0071027) nuclear mRNA surveillance(GO:0071028) |
| 0.0 |
0.2 |
GO:0051611 |
negative regulation of neurotransmitter uptake(GO:0051581) regulation of serotonin uptake(GO:0051611) negative regulation of serotonin uptake(GO:0051612) |
| 0.0 |
0.2 |
GO:0030202 |
heparin metabolic process(GO:0030202) heparin biosynthetic process(GO:0030210) |
| 0.0 |
0.1 |
GO:0046041 |
ITP metabolic process(GO:0046041) |
| 0.0 |
0.1 |
GO:0043006 |
activation of phospholipase A2 activity by calcium-mediated signaling(GO:0043006) |
| 0.0 |
0.2 |
GO:0001502 |
cartilage condensation(GO:0001502) |
| 0.0 |
0.3 |
GO:2000427 |
positive regulation of apoptotic cell clearance(GO:2000427) |
| 0.0 |
0.0 |
GO:0061092 |
regulation of phospholipid translocation(GO:0061091) positive regulation of phospholipid translocation(GO:0061092) |
| 0.0 |
0.0 |
GO:2000616 |
negative regulation of histone H3-K9 acetylation(GO:2000616) |
| 0.0 |
0.0 |
GO:0016095 |
polyprenol catabolic process(GO:0016095) |
| 0.0 |
0.1 |
GO:0002084 |
protein depalmitoylation(GO:0002084) |
| 0.0 |
0.0 |
GO:0045210 |
FasL biosynthetic process(GO:0045210) |
| 0.0 |
0.0 |
GO:0045066 |
regulatory T cell differentiation(GO:0045066) regulation of regulatory T cell differentiation(GO:0045589) |
| 0.0 |
0.0 |
GO:0000472 |
endonucleolytic cleavage to generate mature 5'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000472) rRNA 5'-end processing(GO:0000967) ncRNA 5'-end processing(GO:0034471) |
| 0.0 |
0.1 |
GO:0035694 |
mitochondrial protein catabolic process(GO:0035694) |
| 0.0 |
0.0 |
GO:0007214 |
gamma-aminobutyric acid signaling pathway(GO:0007214) |
| 0.0 |
0.1 |
GO:0030573 |
bile acid catabolic process(GO:0030573) |
| 0.0 |
0.1 |
GO:0002545 |
chronic inflammatory response to non-antigenic stimulus(GO:0002545) positive regulation of chronic inflammatory response(GO:0002678) regulation of chronic inflammatory response to non-antigenic stimulus(GO:0002880) |
| 0.0 |
0.1 |
GO:0016267 |
O-glycan processing, core 1(GO:0016267) |
| 0.0 |
0.1 |
GO:0006452 |
translational frameshifting(GO:0006452) positive regulation of translational termination(GO:0045905) |
| 0.0 |
0.1 |
GO:0048664 |
neuron fate determination(GO:0048664) |
| 0.0 |
0.0 |
GO:0045109 |
intermediate filament organization(GO:0045109) |
| 0.0 |
0.1 |
GO:0031987 |
locomotion involved in locomotory behavior(GO:0031987) |
| 0.0 |
0.1 |
GO:0061073 |
ciliary body morphogenesis(GO:0061073) |
| 0.0 |
0.2 |
GO:1901341 |
activation of store-operated calcium channel activity(GO:0032237) positive regulation of store-operated calcium channel activity(GO:1901341) |
| 0.0 |
0.1 |
GO:0019556 |
histidine catabolic process to glutamate and formamide(GO:0019556) histidine catabolic process to glutamate and formate(GO:0019557) formamide metabolic process(GO:0043606) |
| 0.0 |
0.2 |
GO:0033183 |
negative regulation of histone ubiquitination(GO:0033183) regulation of histone H2A K63-linked ubiquitination(GO:1901314) negative regulation of histone H2A K63-linked ubiquitination(GO:1901315) |
| 0.0 |
0.1 |
GO:0035112 |
genitalia morphogenesis(GO:0035112) |
| 0.0 |
0.1 |
GO:0045229 |
cell envelope organization(GO:0043163) external encapsulating structure organization(GO:0045229) |
| 0.0 |
0.0 |
GO:0071930 |
negative regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0071930) |
| 0.0 |
0.0 |
GO:0099558 |
maintenance of synapse structure(GO:0099558) |
| 0.0 |
0.1 |
GO:0051151 |
negative regulation of smooth muscle cell differentiation(GO:0051151) |
| 0.0 |
0.2 |
GO:0060486 |
Clara cell differentiation(GO:0060486) |
| 0.0 |
0.1 |
GO:0060010 |
Sertoli cell fate commitment(GO:0060010) |
| 0.0 |
0.0 |
GO:0042489 |
negative regulation of odontogenesis of dentin-containing tooth(GO:0042489) |
| 0.0 |
0.1 |
GO:1900748 |
positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
| 0.0 |
0.1 |
GO:1902161 |
positive regulation of cyclic nucleotide-gated ion channel activity(GO:1902161) |
| 0.0 |
0.1 |
GO:0060325 |
face morphogenesis(GO:0060325) |
| 0.0 |
0.1 |
GO:0090073 |
positive regulation of protein homodimerization activity(GO:0090073) |
| 0.0 |
0.0 |
GO:0016256 |
N-glycan processing to lysosome(GO:0016256) |
| 0.0 |
0.1 |
GO:0010716 |
negative regulation of extracellular matrix disassembly(GO:0010716) |
| 0.0 |
0.0 |
GO:0044313 |
protein K6-linked deubiquitination(GO:0044313) |
| 0.0 |
0.1 |
GO:0050689 |
negative regulation of defense response to virus by host(GO:0050689) |
| 0.0 |
0.0 |
GO:0046947 |
hydroxylysine metabolic process(GO:0046946) hydroxylysine biosynthetic process(GO:0046947) |
| 0.0 |
0.1 |
GO:0097646 |
calcitonin family receptor signaling pathway(GO:0097646) amylin receptor signaling pathway(GO:0097647) |
| 0.0 |
0.2 |
GO:0051969 |
regulation of transmission of nerve impulse(GO:0051969) |
| 0.0 |
0.1 |
GO:1903566 |
positive regulation of protein localization to cilium(GO:1903566) |
| 0.0 |
0.1 |
GO:0018283 |
metal incorporation into metallo-sulfur cluster(GO:0018282) iron incorporation into metallo-sulfur cluster(GO:0018283) |
| 0.0 |
0.0 |
GO:0060979 |
vasculogenesis involved in coronary vascular morphogenesis(GO:0060979) |
| 0.0 |
0.1 |
GO:1904742 |
regulation of telomeric DNA binding(GO:1904742) |
| 0.0 |
0.2 |
GO:0032000 |
positive regulation of fatty acid beta-oxidation(GO:0032000) |
| 0.0 |
0.0 |
GO:0035494 |
SNARE complex disassembly(GO:0035494) |
| 0.0 |
0.0 |
GO:1900168 |
glial cell-derived neurotrophic factor secretion(GO:0044467) granulocyte colony-stimulating factor production(GO:0071611) regulation of granulocyte colony-stimulating factor production(GO:0071655) regulation of glial cell-derived neurotrophic factor secretion(GO:1900166) positive regulation of glial cell-derived neurotrophic factor secretion(GO:1900168) |
| 0.0 |
0.1 |
GO:0072752 |
cellular response to rapamycin(GO:0072752) |
| 0.0 |
0.3 |
GO:0035090 |
maintenance of apical/basal cell polarity(GO:0035090) maintenance of epithelial cell apical/basal polarity(GO:0045199) |
| 0.0 |
0.0 |
GO:2000672 |
negative regulation of motor neuron apoptotic process(GO:2000672) |
| 0.0 |
0.1 |
GO:0035624 |
receptor transactivation(GO:0035624) |
| 0.0 |
0.3 |
GO:0006004 |
fucose metabolic process(GO:0006004) |
| 0.0 |
0.0 |
GO:1902728 |
positive regulation of skeletal muscle cell proliferation(GO:0014858) positive regulation of skeletal muscle satellite cell proliferation(GO:1902724) positive regulation of growth factor dependent skeletal muscle satellite cell proliferation(GO:1902728) |
| 0.0 |
0.3 |
GO:1901741 |
positive regulation of myoblast fusion(GO:1901741) |
| 0.0 |
0.1 |
GO:0090261 |
positive regulation of inclusion body assembly(GO:0090261) |
| 0.0 |
0.0 |
GO:0008078 |
mesodermal cell migration(GO:0008078) |
| 0.0 |
0.1 |
GO:0045348 |
positive regulation of MHC class II biosynthetic process(GO:0045348) |
| 0.0 |
0.1 |
GO:0046619 |
optic placode formation(GO:0001743) optic placode formation involved in camera-type eye formation(GO:0046619) |
| 0.0 |
0.0 |
GO:0090149 |
mitochondrial membrane fission(GO:0090149) |
| 0.0 |
0.3 |
GO:0071044 |
histone mRNA catabolic process(GO:0071044) |
| 0.0 |
0.3 |
GO:0034587 |
piRNA metabolic process(GO:0034587) |
| 0.0 |
0.0 |
GO:0071879 |
positive regulation of adrenergic receptor signaling pathway(GO:0071879) |
| 0.0 |
0.1 |
GO:1902336 |
neuropilin signaling pathway(GO:0038189) VEGF-activated neuropilin signaling pathway(GO:0038190) regulation of retinal ganglion cell axon guidance(GO:0090259) positive regulation of retinal ganglion cell axon guidance(GO:1902336) |
| 0.0 |
0.1 |
GO:0035093 |
spermatogenesis, exchange of chromosomal proteins(GO:0035093) |
| 0.0 |
0.0 |
GO:0003084 |
positive regulation of systemic arterial blood pressure(GO:0003084) |
| 0.0 |
0.1 |
GO:0048733 |
sebaceous gland development(GO:0048733) |
| 0.0 |
0.0 |
GO:1904899 |
regulation of hepatic stellate cell proliferation(GO:1904897) positive regulation of hepatic stellate cell proliferation(GO:1904899) hepatic stellate cell proliferation(GO:1990922) |
| 0.0 |
0.0 |
GO:0034145 |
positive regulation of toll-like receptor 4 signaling pathway(GO:0034145) |
| 0.0 |
0.1 |
GO:0045065 |
cytotoxic T cell differentiation(GO:0045065) |
| 0.0 |
0.0 |
GO:0010757 |
negative regulation of plasminogen activation(GO:0010757) |
| 0.0 |
0.0 |
GO:1901030 |
regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900739) positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900740) positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901030) |
| 0.0 |
0.0 |
GO:1901223 |
negative regulation of NIK/NF-kappaB signaling(GO:1901223) |
| 0.0 |
0.0 |
GO:0045081 |
negative regulation of interleukin-10 biosynthetic process(GO:0045081) |
| 0.0 |
0.1 |
GO:0042271 |
susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
| 0.0 |
0.1 |
GO:0002480 |
antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent(GO:0002480) |
| 0.0 |
0.1 |
GO:1902231 |
positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902231) |
| 0.0 |
0.3 |
GO:0006751 |
glutathione catabolic process(GO:0006751) |
| 0.0 |
0.0 |
GO:0060214 |
endocardium morphogenesis(GO:0003160) endocardium formation(GO:0060214) |
| 0.0 |
0.0 |
GO:2000312 |
regulation of kainate selective glutamate receptor activity(GO:2000312) |
| 0.0 |
0.1 |
GO:0032847 |
regulation of cellular pH reduction(GO:0032847) |
| 0.0 |
0.0 |
GO:0048565 |
digestive tract development(GO:0048565) |
| 0.0 |
0.0 |
GO:0071316 |
cellular response to nicotine(GO:0071316) |
| 0.0 |
0.0 |
GO:0060576 |
intestinal epithelial cell development(GO:0060576) |
| 0.0 |
0.0 |
GO:0007350 |
blastoderm segmentation(GO:0007350) |
| 0.0 |
0.0 |
GO:0035502 |
metanephric part of ureteric bud development(GO:0035502) |
| 0.0 |
0.0 |
GO:0060431 |
primary lung bud formation(GO:0060431) |
| 0.0 |
0.0 |
GO:0060837 |
blood vessel endothelial cell differentiation(GO:0060837) |
| 0.0 |
0.1 |
GO:0051547 |
regulation of keratinocyte migration(GO:0051547) |
| 0.0 |
0.1 |
GO:0006657 |
CDP-choline pathway(GO:0006657) |
| 0.0 |
0.0 |
GO:0060029 |
convergent extension involved in organogenesis(GO:0060029) |
| 0.0 |
0.1 |
GO:1900245 |
positive regulation of MDA-5 signaling pathway(GO:1900245) |
| 0.0 |
0.0 |
GO:0036333 |
hepatocyte homeostasis(GO:0036333) response to tetrachloromethane(GO:1904772) |
| 0.0 |
0.1 |
GO:0002032 |
desensitization of G-protein coupled receptor protein signaling pathway by arrestin(GO:0002032) |
| 0.0 |
0.1 |
GO:0070317 |
negative regulation of G0 to G1 transition(GO:0070317) |
| 0.0 |
0.1 |
GO:0061303 |
cornea development in camera-type eye(GO:0061303) |
| 0.0 |
0.4 |
GO:0008535 |
respiratory chain complex IV assembly(GO:0008535) |
| 0.0 |
0.1 |
GO:0010133 |
proline catabolic process(GO:0006562) proline catabolic process to glutamate(GO:0010133) |
| 0.0 |
0.0 |
GO:0071139 |
resolution of recombination intermediates(GO:0071139) resolution of mitotic recombination intermediates(GO:0071140) |
| 0.0 |
0.0 |
GO:0006546 |
glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
| 0.0 |
0.0 |
GO:0071677 |
positive regulation of mononuclear cell migration(GO:0071677) negative regulation of immunological synapse formation(GO:2000521) |
| 0.0 |
0.0 |
GO:0052428 |
modulation of molecular function in other organism(GO:0044359) negative regulation of molecular function in other organism(GO:0044362) negative regulation of molecular function in other organism involved in symbiotic interaction(GO:0052204) modulation of molecular function in other organism involved in symbiotic interaction(GO:0052205) negative regulation by host of symbiont molecular function(GO:0052405) modification by host of symbiont molecular function(GO:0052428) |
| 0.0 |
0.1 |
GO:0006498 |
N-terminal protein lipidation(GO:0006498) |
| 0.0 |
0.0 |
GO:0008347 |
glial cell migration(GO:0008347) |
| 0.0 |
0.1 |
GO:0070574 |
cadmium ion transport(GO:0015691) cadmium ion transmembrane transport(GO:0070574) |
| 0.0 |
0.1 |
GO:0035897 |
proteolysis in other organism(GO:0035897) |
| 0.0 |
0.0 |
GO:2000977 |
regulation of forebrain neuron differentiation(GO:2000977) |
| 0.0 |
0.1 |
GO:0071910 |
determination of liver left/right asymmetry(GO:0071910) |
| 0.0 |
0.0 |
GO:0006617 |
SRP-dependent cotranslational protein targeting to membrane, signal sequence recognition(GO:0006617) |
| 0.0 |
0.0 |
GO:0098972 |
dendritic transport of mitochondrion(GO:0098939) anterograde dendritic transport of mitochondrion(GO:0098972) |
| 0.0 |
0.1 |
GO:0018103 |
protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
| 0.0 |
0.2 |
GO:1904714 |
regulation of chaperone-mediated autophagy(GO:1904714) |
| 0.0 |
0.1 |
GO:0032098 |
regulation of appetite(GO:0032098) |
| 0.0 |
0.1 |
GO:0038165 |
oncostatin-M-mediated signaling pathway(GO:0038165) |
| 0.0 |
0.0 |
GO:1905097 |
regulation of guanyl-nucleotide exchange factor activity(GO:1905097) |
| 0.0 |
0.1 |
GO:0060586 |
multicellular organismal iron ion homeostasis(GO:0060586) |
| 0.0 |
0.2 |
GO:0031069 |
hair follicle morphogenesis(GO:0031069) |
| 0.0 |
0.0 |
GO:0034395 |
regulation of transcription from RNA polymerase II promoter in response to iron(GO:0034395) divalent metal ion export(GO:0070839) |
| 0.0 |
0.2 |
GO:0071850 |
mitotic cell cycle arrest(GO:0071850) |
| 0.0 |
0.3 |
GO:0032757 |
positive regulation of interleukin-8 production(GO:0032757) |
| 0.0 |
0.0 |
GO:0006601 |
creatine biosynthetic process(GO:0006601) |
| 0.0 |
0.1 |
GO:2000973 |
regulation of pro-B cell differentiation(GO:2000973) |
| 0.0 |
0.2 |
GO:1901550 |
regulation of endothelial cell development(GO:1901550) regulation of establishment of endothelial barrier(GO:1903140) |
| 0.0 |
0.0 |
GO:0046629 |
gamma-delta T cell activation(GO:0046629) |
| 0.0 |
0.0 |
GO:0035434 |
copper ion transmembrane transport(GO:0035434) |
| 0.0 |
0.0 |
GO:0035574 |
histone H4-K20 demethylation(GO:0035574) |
| 0.0 |
0.0 |
GO:0060462 |
lung lobe development(GO:0060462) lung lobe morphogenesis(GO:0060463) |
| 0.0 |
0.0 |
GO:2000696 |
regulation of epithelial cell differentiation involved in kidney development(GO:2000696) |
| 0.0 |
0.0 |
GO:0006844 |
acyl carnitine transport(GO:0006844) acyl carnitine transmembrane transport(GO:1902616) |
| 0.0 |
0.1 |
GO:0035865 |
cellular response to potassium ion(GO:0035865) |
| 0.0 |
0.0 |
GO:0006414 |
translational elongation(GO:0006414) |
| 0.0 |
0.1 |
GO:0015712 |
hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
| 0.0 |
0.1 |
GO:0045586 |
regulation of gamma-delta T cell differentiation(GO:0045586) |
| 0.0 |
0.3 |
GO:0034063 |
stress granule assembly(GO:0034063) |
| 0.0 |
0.0 |
GO:0015917 |
aminophospholipid transport(GO:0015917) |
| 0.0 |
0.0 |
GO:0042832 |
defense response to protozoan(GO:0042832) |
| 0.0 |
0.1 |
GO:0039663 |
fusion of virus membrane with host plasma membrane(GO:0019064) membrane fusion involved in viral entry into host cell(GO:0039663) multi-organism membrane fusion(GO:0044800) |
| 0.0 |
0.2 |
GO:0010839 |
negative regulation of keratinocyte proliferation(GO:0010839) |
| 0.0 |
0.1 |
GO:0090158 |
endoplasmic reticulum membrane organization(GO:0090158) |
| 0.0 |
0.1 |
GO:1903944 |
negative regulation of myoblast fusion(GO:1901740) regulation of hepatocyte apoptotic process(GO:1903943) negative regulation of hepatocyte apoptotic process(GO:1903944) |
| 0.0 |
0.0 |
GO:0007198 |
adenylate cyclase-inhibiting serotonin receptor signaling pathway(GO:0007198) |
| 0.0 |
0.0 |
GO:1903903 |
regulation of establishment of T cell polarity(GO:1903903) |
| 0.0 |
0.1 |
GO:0045861 |
negative regulation of proteolysis(GO:0045861) |
| 0.0 |
0.1 |
GO:0071468 |
cellular response to acidic pH(GO:0071468) |
| 0.0 |
0.0 |
GO:0023021 |
termination of signal transduction(GO:0023021) |
| 0.0 |
0.1 |
GO:0018343 |
protein farnesylation(GO:0018343) |
| 0.0 |
0.0 |
GO:1905000 |
regulation of membrane repolarization during atrial cardiac muscle cell action potential(GO:1905000) |
| 0.0 |
0.0 |
GO:0061469 |
regulation of type B pancreatic cell proliferation(GO:0061469) |
| 0.0 |
0.1 |
GO:0051639 |
actin filament network formation(GO:0051639) |
| 0.0 |
0.2 |
GO:0051770 |
positive regulation of nitric-oxide synthase biosynthetic process(GO:0051770) |
| 0.0 |
0.0 |
GO:0006659 |
phosphatidylserine biosynthetic process(GO:0006659) |
| 0.0 |
0.0 |
GO:2000546 |
positive regulation of cell chemotaxis to fibroblast growth factor(GO:1904849) positive regulation of endothelial cell chemotaxis to fibroblast growth factor(GO:2000546) |
| 0.0 |
0.0 |
GO:0048203 |
vesicle targeting, trans-Golgi to endosome(GO:0048203) |
| 0.0 |
0.0 |
GO:0097466 |
protein deglycosylation involved in glycoprotein catabolic process(GO:0035977) glycoprotein ERAD pathway(GO:0097466) mannose trimming involved in glycoprotein ERAD pathway(GO:1904382) |
| 0.0 |
0.0 |
GO:0070309 |
lens fiber cell morphogenesis(GO:0070309) |
| 0.0 |
0.0 |
GO:0034553 |
respiratory chain complex II assembly(GO:0034552) mitochondrial respiratory chain complex II assembly(GO:0034553) mitochondrial respiratory chain complex II biogenesis(GO:0097032) |
| 0.0 |
0.1 |
GO:0033387 |
putrescine biosynthetic process from ornithine(GO:0033387) |
| 0.0 |
0.1 |
GO:0035562 |
negative regulation of chromatin binding(GO:0035562) |
| 0.0 |
0.0 |
GO:1903625 |
negative regulation of DNA catabolic process(GO:1903625) |
| 0.0 |
0.1 |
GO:0071596 |
ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
| 0.0 |
0.1 |
GO:0048625 |
myoblast fate commitment(GO:0048625) |
| 0.0 |
0.2 |
GO:0009313 |
oligosaccharide catabolic process(GO:0009313) |
| 0.0 |
0.2 |
GO:0071816 |
tail-anchored membrane protein insertion into ER membrane(GO:0071816) |
| 0.0 |
0.1 |
GO:0060613 |
fat pad development(GO:0060613) |
| 0.0 |
0.1 |
GO:0019368 |
fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
| 0.0 |
0.1 |
GO:0070987 |
error-free translesion synthesis(GO:0070987) |
| 0.0 |
0.1 |
GO:0021626 |
hindbrain maturation(GO:0021578) cerebellum maturation(GO:0021590) central nervous system maturation(GO:0021626) cerebellar cortex maturation(GO:0021699) |
| 0.0 |
0.1 |
GO:0030011 |
maintenance of cell polarity(GO:0030011) |
| 0.0 |
0.1 |
GO:0051918 |
negative regulation of fibrinolysis(GO:0051918) |
| 0.0 |
0.0 |
GO:0033037 |
polysaccharide localization(GO:0033037) |
| 0.0 |
0.0 |
GO:0019243 |
methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione(GO:0019243) methylglyoxal catabolic process(GO:0051596) methylglyoxal catabolic process to lactate(GO:0061727) |
| 0.0 |
0.0 |
GO:0006616 |
SRP-dependent cotranslational protein targeting to membrane, translocation(GO:0006616) |
| 0.0 |
0.2 |
GO:0010992 |
ubiquitin homeostasis(GO:0010992) |
| 0.0 |
0.0 |
GO:0033127 |
regulation of histone phosphorylation(GO:0033127) |
| 0.0 |
0.0 |
GO:0031293 |
membrane protein intracellular domain proteolysis(GO:0031293) |
| 0.0 |
0.0 |
GO:0072008 |
glomerular mesangial cell differentiation(GO:0072008) |
| 0.0 |
0.0 |
GO:0006427 |
histidyl-tRNA aminoacylation(GO:0006427) |
| 0.0 |
0.0 |
GO:0008612 |
peptidyl-lysine modification to peptidyl-hypusine(GO:0008612) |
| 0.0 |
0.1 |
GO:0006127 |
glycerophosphate shuttle(GO:0006127) |
| 0.0 |
0.2 |
GO:0051973 |
positive regulation of telomerase activity(GO:0051973) |
| 0.0 |
0.1 |
GO:1905167 |
regulation of lysosomal protein catabolic process(GO:1905165) positive regulation of lysosomal protein catabolic process(GO:1905167) |
| 0.0 |
0.0 |
GO:2000588 |
positive regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000588) |
| 0.0 |
0.1 |
GO:0038028 |
insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
| 0.0 |
0.0 |
GO:0001831 |
trophectodermal cellular morphogenesis(GO:0001831) |
| 0.0 |
0.0 |
GO:1903028 |
positive regulation of opsonization(GO:1903028) |
| 0.0 |
0.0 |
GO:0061042 |
vascular wound healing(GO:0061042) |
| 0.0 |
0.0 |
GO:0050680 |
negative regulation of epithelial cell proliferation(GO:0050680) |
| 0.0 |
0.1 |
GO:0009233 |
menaquinone metabolic process(GO:0009233) |
